These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 33852961)

  • 21. A decade of liver organoids: Advances in disease modeling.
    Liu Y; Sheng JY; Yang CF; Ding J; Chan YS
    Clin Mol Hepatol; 2023 Jul; 29(3):643-669. PubMed ID: 36880210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Organoids to model liver disease.
    Nuciforo S; Heim MH
    JHEP Rep; 2021 Feb; 3(1):100198. PubMed ID: 33241206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three-dimensional testicular organoid: a novel tool for the study of human spermatogenesis and gonadotoxicity in vitro.
    Pendergraft SS; Sadri-Ardekani H; Atala A; Bishop CE
    Biol Reprod; 2017 Mar; 96(3):720-732. PubMed ID: 28339648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Organoids: A new approach in toxicity testing of nanotherapeutics.
    Nabi SU; Ali SI; Rather MA; Sheikh WM; Altaf M; Singh H; Mumtaz PT; Mishra NC; Nazir SU; Bashir SM
    J Appl Toxicol; 2022 Jan; 42(1):52-72. PubMed ID: 34060108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The phosphatidylethanolamine biosynthesis pathway provides a new target for cancer chemotherapy.
    Guan Y; Chen X; Wu M; Zhu W; Arslan A; Takeda S; Nguyen MH; Majeti R; Thomas D; Zheng M; Peltz G
    J Hepatol; 2020 Apr; 72(4):746-760. PubMed ID: 31760071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishment of 2.5D organoid culture model using 3D bladder cancer organoid culture.
    Abugomaa A; Elbadawy M; Yamanaka M; Goto Y; Hayashi K; Mori T; Uchide T; Azakami D; Fukushima R; Yoshida T; Shibutani M; Yamashita R; Kobayashi M; Yamawaki H; Shinohara Y; Kaneda M; Usui T; Sasaki K
    Sci Rep; 2020 Jun; 10(1):9393. PubMed ID: 32523078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critical analysis of 3-D organoid in vitro cell culture models for high-throughput drug candidate toxicity assessments.
    Astashkina A; Grainger DW
    Adv Drug Deliv Rev; 2014 Apr; 69-70():1-18. PubMed ID: 24613390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of porcine gastrointestinal organoid units as a potential in vitro tool for drug discovery and development.
    Olayanju A; Jones L; Greco K; Goldring CE; Ansari T
    J Appl Toxicol; 2019 Jan; 39(1):4-15. PubMed ID: 29893059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in Central Nervous System Organoids: A Focus on Organoid-Based Models for Motor Neuron Disease.
    Vieira de Sá R; Cañizares Luna M; Pasterkamp RJ
    Tissue Eng Part C Methods; 2021 Mar; 27(3):213-224. PubMed ID: 33446055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver-Tumor Hybrid Organoids for Modeling Tumor Growth and Drug Response In Vitro.
    Skardal A; Devarasetty M; Rodman C; Atala A; Soker S
    Ann Biomed Eng; 2015 Oct; 43(10):2361-73. PubMed ID: 25777294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human liver organoid models for assessment of drug toxicity at the preclinical stage.
    Karabicici M; Akbari S; Ertem O; Gumustekin M; Erdal E
    Endocr Metab Immune Disord Drug Targets; 2023 Apr; ():. PubMed ID: 37055905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bronchioalveolar organoids: A preclinical tool to screen toxicity associated with antibody-drug conjugates.
    McCray TN; Nguyen V; Heins JS; Nguyen E; Stewart K; Ford CT; Neace C; Gupta P; Ortiz DJ
    Toxicol Appl Pharmacol; 2024 Apr; 485():116886. PubMed ID: 38452946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced human developmental toxicity and teratogenicity assessment using human organoid models.
    Li M; Gong J; Gao L; Zou T; Kang J; Xu H
    Ecotoxicol Environ Saf; 2022 Apr; 235():113429. PubMed ID: 35325609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
    Ho BX; Pek NMQ; Soh BS
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3D organoid-derived human glomeruli for personalised podocyte disease modelling and drug screening.
    Hale LJ; Howden SE; Phipson B; Lonsdale A; Er PX; Ghobrial I; Hosawi S; Wilson S; Lawlor KT; Khan S; Oshlack A; Quinlan C; Lennon R; Little MH
    Nat Commun; 2018 Dec; 9(1):5167. PubMed ID: 30514835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validating Well-Functioning Hepatic Organoids for Toxicity Evaluation.
    Choi SY; Kim TH; Kim MJ; Mun SJ; Kim TS; Jung KK; Oh IU; Oh JH; Son MJ; Lee JH
    Toxics; 2024 May; 12(5):. PubMed ID: 38787150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testing Susceptibility of Patient-Derived Organoid Cultures to Therapies: Pharmacotyping.
    Burkhart RA; Baker LA; Tiriac H
    Methods Mol Biol; 2018; 1787():253-261. PubMed ID: 29736724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity.
    Tanaka N; Osman AA; Takahashi Y; Lindemann A; Patel AA; Zhao M; Takahashi H; Myers JN
    Oral Oncol; 2018 Dec; 87():49-57. PubMed ID: 30527243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insights to Heart Development and Cardiac Disease Models Using Pluripotent Stem Cell Derived 3D Organoids.
    Pang JKS; Ho BX; Chan WK; Soh BS
    Front Cell Dev Biol; 2021; 9():788955. PubMed ID: 34926467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-dimensional liver-derived extracellular matrix hydrogel promotes liver organoids function.
    Saheli M; Sepantafar M; Pournasr B; Farzaneh Z; Vosough M; Piryaei A; Baharvand H
    J Cell Biochem; 2018 Jun; 119(6):4320-4333. PubMed ID: 29247536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.